{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:50:43Z","timestamp":1774317043988,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012272","name":"Shenzhen Technology Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004509","name":"Health Commission of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100424"],"award-info":[{"award-number":["82100424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpet.2025.103692","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:28:41Z","timestamp":1756913321000},"page":"103692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Morusin reverses paclitaxel resistance by inhibiting the stem cell\u2013like properties of non\u2013small cell lung cancer in a \u03b2-catenin\u2013dependent manner"],"prefix":"10.1016","volume":"392","author":[{"given":"Huaming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103692_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.jpet.2025.103692_bib2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.6004\/jnccn.2012.0130","article-title":"Non-small cell lung cancer","volume":"10","author":"Ettinger","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.jpet.2025.103692_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jpet.2025.103692_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/14737140.2014.881719","article-title":"Nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer","volume":"14","author":"Hirsh","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"issue":"39","key":"10.1016\/j.jpet.2025.103692_bib5","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.2174\/0929867326666191016113631","article-title":"Recent advances in elucidating paclitaxel resistance mechanisms in non-small cell lung cancer and strategies to overcome drug resistance","volume":"27","author":"Cui","year":"2020","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jpet.2025.103692_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110623","article-title":"Hypoxia-mediated cancer stem cell resistance and targeted therapy","volume":"130","author":"Sun","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.jpet.2025.103692_bib7","first-page":"689","article-title":"Cancer stem cells and immunoresistance: clinical implications and solutions","volume":"4","author":"Codony-Servat","year":"2015","journal-title":"Transl Lung Cancer Res"},{"issue":"4","key":"10.1016\/j.jpet.2025.103692_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.2011.01738.x","article-title":"Y654 of \u03b2-catenin is essential for FLT3\/ITD-related tyrosine phosphorylation and nuclear localization of \u03b2-catenin","volume":"88","author":"Kajiguchi","year":"2012","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103692_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/09168451.2018.1431518","article-title":"Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt\/\u03b2-catenin signaling in gastric cancer cells","volume":"82","author":"Xu","year":"2018","journal-title":"Biosci Biotechnol Biochem"},{"issue":"8","key":"10.1016\/j.jpet.2025.103692_bib10","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1158\/0008-5472.CAN-20-2801","article-title":"YAP and \u03b2-catenin cooperate to drive oncogenesis in basal breast cancer","volume":"81","author":"Quinn","year":"2021","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jpet.2025.103692_bib11","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002594R","article-title":"Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of \u03b2-catenin: evidence of inhibition of Wnt\/\u03b2-catenin signaling as an important antitumor mechanism of microtubule-targeting agents","volume":"35","author":"Kumari","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.jpet.2025.103692_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.1609981","article-title":"Aberrant expression of \u03b2-catenin correlates with infiltrating immune cells and prognosis in NSCLC","volume":"27","author":"Zheng","year":"2021","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103692_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/etm.2021.10927","article-title":"Altered Wnt5a expression affects radiosensitivity of non-small cell lung cancer via the Wnt\/\u03b2-catenin pathway","volume":"23","author":"Li","year":"2022","journal-title":"Exp Ther Med"},{"issue":"9","key":"10.1016\/j.jpet.2025.103692_bib14","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/jcb.30304","article-title":"Evodiamine inhibits stemness and metastasis by altering the SOX9-\u03b2-catenin axis in non-small-cell lung cancer","volume":"123","author":"Panda","year":"2022","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jpet.2025.103692_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110225","article-title":"Inhibition of Wnt\/\u03b2-catenin pathway reverses multi-drug resistance and EMT in Oct4+\/Nanog+ NSCLC cells","volume":"127","author":"Liu","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/j.jpet.2025.103692_bib16","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/cells10082065","article-title":"miR193a-5p mediated ZNF746 and c-Myc signaling axis is critically involved in morusin induced apoptosis in colorectal cancer cells","volume":"10","author":"Park","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.jpet.2025.103692_bib17","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1002\/ptr.7913","article-title":"Apoptotic and anti-Warburg effect of morusin via ROS mediated inhibition of FOXM1\/c-Myc signaling in prostate cancer cells","volume":"37","author":"Koo","year":"2023","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103692_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2018.09.085","article-title":"Induction of apoptosis by morusin in human non-small cell lung cancer cells by suppression of EGFR\/STAT3 activation","volume":"505","author":"Park","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jpet.2025.103692_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mc.22260","article-title":"Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction","volume":"55","author":"Guo","year":"2016","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jpet.2025.103692_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107675","article-title":"Morusin suppresses the stemness characteristics of gastric cancer cells induced by hypoxic microenvironment through inhibition of HIF-1\u03b1 accumulation","volume":"241","author":"Chen","year":"2024","journal-title":"Toxicon"},{"issue":"23","key":"10.1016\/j.jpet.2025.103692_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316611","article-title":"Metformin suppresses stemness of non-small-cell lung cancer induced by paclitaxel through FOXO3a","volume":"24","author":"Tang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jpet.2025.103692_bib22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41401-023-01219-y","article-title":"Targeted inhibition of the HNF1A\/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.jpet.2025.103692_bib23","first-page":"504","article-title":"Morusin suppresses A549 cell migration and induces cell apoptosis by downregulating the expression of COX-2 and VEGF genes","volume":"40","author":"Yin","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jpet.2025.103692_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109279","article-title":"Morusin induces apoptosis and autophagy via JNK, ERK and PI3K\/Akt signaling in human lung carcinoma cells","volume":"331","author":"Wang","year":"2020","journal-title":"Chem Biol Interact"},{"issue":"2","key":"10.1016\/j.jpet.2025.103692_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1271\/bbb.110797","article-title":"Relationship between the structures of taxane derivatives and their microtubule polymerization activity","volume":"76","author":"Hidaka","year":"2012","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.jpet.2025.103692_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.podrm.2018.11.001","article-title":"Paclitaxel","volume":"44","author":"Alqahtani","year":"2019","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103692_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2001-1326-2-3","article-title":"Mechanisms of chemoresistance in cancer stem cells","volume":"2","author":"Abdullah","year":"2013","journal-title":"Clin Transl Med"},{"issue":"6","key":"10.1016\/j.jpet.2025.103692_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065158","article-title":"ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis","volume":"8","author":"Kuroda","year":"2013","journal-title":"PLOS One"},{"issue":"22","key":"10.1016\/j.jpet.2025.103692_bib29","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.7150\/jca.62123","article-title":"Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells","volume":"12","author":"Liu","year":"2021","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.jpet.2025.103692_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/ijmr.IJMR_709_20","article-title":"ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy","volume":"154","author":"Javed","year":"2021","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jpet.2025.103692_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109940","article-title":"ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with \u03b2-catenin","volume":"125","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2025.103692_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1026278","article-title":"ALDH1: a potential therapeutic target for cancer stem cells in solid tumors","volume":"12","author":"Wei","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jpet.2025.103692_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109067","article-title":"\u0394Np63\u03b1 mediates sulforaphane suppressed colorectal cancer stem cell properties through transcriptional regulation of Nanog\/Oct4\/Sox2","volume":"107","author":"Chen","year":"2022","journal-title":"J Nutr Biochem"},{"issue":"9","key":"10.1016\/j.jpet.2025.103692_bib34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/cancers11091331","article-title":"Elimination of SOX2\/OCT4-associated prostate cancer stem cells blocks tumor development and enhances therapeutic response","volume":"11","author":"Vaddi","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.jpet.2025.103692_bib35","first-page":"727","article-title":"Lung adenocarcinoma resistance to therapy with EGFR-tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG","volume":"43","author":"Hu","year":"2020","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/j.jpet.2025.103692_bib36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1080\/15384101.2021.1919826","article-title":"PAF enhances cancer stem cell properties via \u03b2-catenin signaling in hepatocellular carcinoma","volume":"20","author":"Li","year":"2021","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.jpet.2025.103692_bib37","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/cbin.11314","article-title":"miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt\/\u03b2-catenin signaling pathway","volume":"44","author":"Tian","year":"2020","journal-title":"Cell Biol Int"},{"issue":"10","key":"10.1016\/j.jpet.2025.103692_bib38","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/ijc.32728","article-title":"A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt\/\u03b2-catenin signaling","volume":"146","author":"Hwang","year":"2020","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.jpet.2025.103692_bib39","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/jcp.25706","article-title":"NOR1 suppresses cancer stem-like cells properties of tumor cells via the inhibition of the AKT-GSK-3\u03b2-Wnt\/ \u03b2-catenin-ALDH1A1 signal circuit","volume":"232","author":"Wang","year":"2017","journal-title":"J Cell Physiol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103692_bib40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/biomedicines9060637","article-title":"The core stem genes SOX2, POU5F1\/OCT4, and NANOG are expressed in human parathyroid tumors and modulated by MEN1, YAP1, and \u03b2-catenin pathways activation","volume":"9","author":"Verdelli","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jpet.2025.103692_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/fcp.12583","article-title":"Targeting Wnt\/\u03b2-catenin by anthelmintic drug niclosamide overcomes paclitaxel resistance in esophageal cancer","volume":"35","author":"Wei","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"issue":"37","key":"10.1016\/j.jpet.2025.103692_bib42","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1038\/s41388-020-01390-0","article-title":"DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT\/\u03b2-catenin signaling and cancer stem cell traits","volume":"39","author":"Chi","year":"2020","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.jpet.2025.103692_bib43","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1158\/1078-0432.CCR-22-0791","article-title":"FOXM1 variant contributes to gefitinib resistance via activating Wnt\/\u03b2-catenin signal pathway in patients with non-small cell lung cancer","volume":"28","author":"Guan","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103692_bib44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/ijms23010450","article-title":"Wnt\/\u03b2-catenin signaling contributes to paclitaxel resistance in bladder cancer cells with cancer stem cell-like properties","volume":"23","author":"Jim\u00e9nez-Guerrero","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jpet.2025.103692_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.4884","article-title":"Morusin inhibits the growth of human colorectal cancer HCT116-derived sphere-forming cells via the inactivation of Akt pathway","volume":"47","author":"Zhou","year":"2021","journal-title":"Int J Mol Med"},{"issue":"57","key":"10.1016\/j.jpet.2025.103692_bib46","doi-asserted-by":"crossref","first-page":"32621","DOI":"10.1039\/C8RA06362A","article-title":"Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy","volume":"8","author":"Agarwal","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.jpet.2025.103692_bib47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcis.2022.04.090","article-title":"Carrier free nanomedicine for synergistic cancer therapy by initiating apoptosis and paraptosis","volume":"622","author":"Zheng","year":"2022","journal-title":"J Colloid Interface Sci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525399052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525399052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:58:17Z","timestamp":1761850697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525399052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022356525399052"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103692","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morusin reverses paclitaxel resistance by inhibiting the stem cell\u2013like properties of non\u2013small cell lung cancer in a \u03b2-catenin\u2013dependent manner","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103692"}}